loader image

Accessing the inaccessible

Reimagining Small Molecule Therapeutics through AI

Pushing the boundaries of what is possible with small molecule therapeutics

PharmEnable therapeutics - targeting unaccessible targets

Targeting inaccessible targets in the brain and inside the cell.

PharmEnable Therapeutics - replicating specificity of biologics

Bringing the specificity of biologics to small molecule drug design.

PharmEnable therapeutics - unlocking chemical space

Unlocking novel chemical space through AI-enabled drug discovery.

Developing life changing medicines for cancer and neurological disease

Explore our rapidly growing pipeline.

PharmEnable Therapeutics team - 1000px

Meet our world-class team

We are a spin-out based on ground-breaking research
from the University of Cambridge, UK

News & Updates

Read up on the latest news, updates and announcements from the PharmEnable team.

Supported by:

MP Healthcare
University of Cambridge Enterprise
Martlet logo
Cambridge Angels
Wren Capital
o2h ventures
Paul Forster
Meltwind Capital
KQ Labs Logo
R42 Logo